At the Annual General Meeting in Viking Supply Ships AB (publ) held on 26 March 2025 in Gothenburg, the following main resolutions were adopted. The group's and the company's income statement for ...
Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its investigational obesity drug, VK2735, as the biotech positions itself to ...
Credit: SOPA Images via Getty Images. Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its investigational obesity drug, VK2735, as ...
The deal comes as Viking prepares to start late-stage testing of an injectable form of the therapy, VK2735, by the end of June. The company said in February it has enough drug supply to complete ...
Analysts acknowledged the long-term manufacturing deal could dull Viking’s takeout prospects but hailed it as a smart move to ensure supply. Viking Therapeutics is putting $150 million down to secure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results